This is a classic toxic convertible from Yorkville Advisors — expect aggressive short-selling by the fund as it converts and flips shares. The full-ratchet anti-dilution means any future equity issuance will further hammer the conversion price. Monitor for the registration statement filing (due ~June 6, 2026) — once effective, Yorkville can begin converting and selling. The stock is likely to face persistent downward pressure from this overhang.
Price Chart
Executive Summary
Evolution Metals & Technologies Corp. entered into a securities purchase agreement with YA II PN, Ltd. (Yorkville Advisors) to issue up to $100M in convertible debentures, with $20M funded at the first closing. The debentures carry a 5% interest rate, mature in 18 months, and are convertible into common shares at the lower of $12.09 or 95% of the 5-day VWAP (floor $1.86). The company also granted registration rights for the underlying shares. This is a highly dilutive, structured financing from a known distressed-debt investor, signaling significant cash needs and potential for severe dilution.
Key Financial Metrics
Key Facts
- Up to $100M in convertible debentures sold to Yorkville Advisors (YA II PN, Ltd.), with $20M funded at first closing on May 7, 2026
- Debentures mature November 7, 2027, carry 5% interest (18% on default), and are convertible at the lower of $12.09 fixed price or 95% of the 5-day VWAP (floor $1.86)
- Conversion price includes full-ratchet anti-dilution protection — any future issuance below the fixed price automatically resets the conversion price lower
- Company has 593,349,852 shares outstanding; the conversion of the full $100M at the floor price of $1.86 would add ~53.8M shares (~9% dilution), but at current prices dilution could be far higher
- Yorkville is a well-known provider of toxic convertible financing to distressed companies — this structure is typical of a 'death spiral' convertible
- Registration rights agreement requires filing a resale registration statement within 30 days and effectiveness within 60 days
- Company covenants not to enter into any other variable-rate transactions without Yorkville's consent during the life of the debentures
Financial Impact
Up to $100M in new debt, with $20M drawn immediately. Conversion at the floor price of $1.86 would add ~53.8M shares (~9% dilution) on the full $100M, but actual dilution depends on stock price at conversion — lower prices mean more shares. The 5% payment premium and 5% interest add ~$5M in costs on the first tranche alone.
Risk Factors
- Severe dilution from conversion of debentures at low stock prices — the floor price of $1.86 means Yorkville can convert at increasingly lower prices as the stock declines
- Full-ratchet anti-dilution provision means any future equity raise below $12.09 will further reduce the conversion price, compounding dilution
- Yorkville has a track record of short-selling the stocks it finances — the 4.99% beneficial ownership blocker is the only limit on its ability to convert and sell
- The company may be unable to meet the registration deadline, triggering amortization payments of $4M/month plus 5% premium
- If the stock trades below the floor price for 5 of 7 days, an amortization event is triggered, forcing cash repayments the company may not have
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-054183 |
| Document: ea029007301ex4-1.htm | 0001213900-26-054183 |
| Document: ea029007301ex4-2.htm | 0001213900-26-054183 |
| Document: ea029007301ex10-2.htm | 0001213900-26-054183 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 8-K | $1.54 | awaiting T+20 | — | $1.41 (−8.44%) |
Oct 15, 2026 11d ago | Press Release | $1.54 | awaiting T+20 | — | $1.41 (−8.44%) |
Oct 14, 2026 12d ago | 8-K | $1.50 | awaiting T+20 | — | $1.41 (−6.00%) |
Oct 13, 2026 13d ago | EFFECT | $1.43 | awaiting T+20 | — | $1.41 (+1.05%) |
Oct 9, 2026 17d ago | 8-K | $1.64 | awaiting T+20 | — | $1.41 (−14.02%) |
Oct 8, 2026 18d ago | 3 | $1.64 | awaiting T+20 | — | $1.41 (−14.02%) |
Oct 6, 2026 20d ago | Press Release | $1.92 | awaiting T+20 | — | $1.41 (−26.56%) |
Oct 6, 2026 20d ago | 8-K | $1.92 | awaiting T+20 | — | $1.41 (−26.56%) |
Oct 6, 2026 20d ago | EFFECT | $1.92 | awaiting T+20 | — | $1.41 (+26.56%) |
Oct 5, 2026 21d ago | S-1 | $1.92 | awaiting T+20 | — | $1.41 (+26.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers